Skip to main content

. 1987 May;50(5):636–637. doi: 10.1136/jnnp.50.5.636

Pituitary apoplexy following isosorbide administration.

J S Bevan, A M Oza, C W Burke, C B Adams

PMCID: PMC1031981 PMID: 3585391

636

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bernstein M., Hegele R. A., Gentili F., Brothers M., Holgate R., Sturtridge W. C., Deck J. Pituitary apoplexy associated with a triple bolus test. Case report. J Neurosurg. 1984 Sep;61(3):586–590. doi: 10.3171/jns.1984.61.3.0586. [DOI] [PubMed] [Google Scholar]
Mueller R. A., Meienberg O. Hemicrania with oculosympathetic paresis from isosorbide dinitrate. N Engl J Med. 1983 Feb 24;308(8):458–459. [PubMed] [Google Scholar]
Purvin V. A., Dunn D. W. Nitrate-induced transient ischemic attacks. South Med J. 1981 Sep;74(9):1130–1131. doi: 10.1097/00007611-198109000-00029. [DOI] [PubMed] [Google Scholar]
Taylor T., Chasseaud L. F., Major R., Doyle E., Darragh A. Isosorbide 5-mononitrate pharmacokinetics in humans. Biopharm Drug Dispos. 1981 Jul-Sep;2(3):255–263. doi: 10.1002/bdd.2510020306. [DOI] [PubMed] [Google Scholar]
Wakai S., Fukushima T., Teramoto A., Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg. 1981 Aug;55(2):187–193. doi: 10.3171/jns.1981.55.2.0187. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES